Quetiapine Fumarate XR Tablets
SOL #: SPE2D223D0012Award Notice
Overview
Buyer
DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States
Place of Performance
Hauppauge, NY
NAICS
Pharmaceutical Preparation Manufacturing (325412)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Sep 7, 2023
2
Last Updated
Sep 26, 2024
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Modification SPE2D223D0012 P00001 to change the price effective date from December 17, 2023 to October 18, 2023.
Modification SPE2D223D0012 P00001 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract.
Award SPE2D223D0012 Quetiapine Fumarate XR Tablets
People
Points of Contact
Phyllis DaraioPRIMARY